| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.3 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.3 |